Rockwell Medical, Inc. RMTI
7.08 USD 0.00 (+0.00%)
At closeNov 11, 2026, 4:00 PM EST
7.14 +0.06 +0.85%
After hours · Nov 11, 4:00 PM ET
Day range unavailable
4.89 52-week range 12.90
- YTD
- -14.70%
- 1 year
- -32.57%
News
benzinga.com Rockwell Medical Q3 2026 Earnings Call Transcript Rockwell Medical (NASDAQ:RMTI) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought…
zacks.com Rockwell Medical (RMTI) Reports Q3 Loss, Tops Revenue Estimates Rockwell Medical (RMTI) came out with a quarterly loss of $0.59 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to a loss of $0.5 per share a year ago.
businesswire.com Rockwell Medical Announces Third Quarter 2026 Results WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical announces Q3'26 results, grew net sales 20% YoY reflecting strong customer adoption of our hemodialysis concentrates…
benzinga.com Rockwell Medical To Acquire Majority Of Vantive's Hemodialysis Business; Terms Not Disclosed Vantive, a vital organ therapy company with a 70-year legacy of kidney care innovation, today announced that it has entered into a definitive agreement with Rockwell Medical, Inc. (NASDAQ:RMTI) to…
benzinga.com HC Wainwright & Co. Reiterates Buy on Rockwell Medical, Maintains $20 Price Target HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Rockwell Medical (NASDAQ:RMTI) with a Buy and maintains $20 price target.
benzinga.com Rockwell Medical Q2 Adj. EPS $(0.04) Beats $(0.23) Estimate, Sales $17.780M Miss $17.837M Estimate Rockwell Medical (NASDAQ:RMTI) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.23) by 82.61 percent. This is a 300 percent decrease over losses of…
benzinga.com Rockwell Medical Affirms FY2026 Sales Guidance of $70.000M-$75.000M vs $72.469M Est Rockwell Medical (NASDAQ:RMTI) affirms FY2026 sales outlook from $70.000 million-$75.000 million to $70.000 million-$75.000 million vs $72.469 million estimate.
benzinga.com Rockwell Medical Stock Keeps Nasdaq Listing After Compliance Notice Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers…- benzinga.com HC Wainwright & Co. Maintains Buy on Rockwell Medical, Raises Price Target to $20 HC Wainwright & Co. analyst Raghuram Selvaraju maintains Rockwell Medical (NASDAQ:RMTI) with a Buy and raises the price target from $2 to $20.
- benzinga.com Rockwell Medical Plans 1-for-10 Reverse Stock Split Next Week Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers…
benzinga.com What's Going On With Rockwell Medical Stock Wednesday? Rockwell Medical (RMTI) spikes 6.4% premarket. Discover key support and resistance levels as the stock tests its 20-day moving average.
benzinga.com Rockwell Medical Renews And Extends Its Product Purchase Agreement With aQua Dialysis The Agreement, which includes supply and purchasing commitments, will be in effect for two years with options to renew for two additional one-year periods. Under the Agreement, Rockwell Medical will…- benzinga.com Rockwell Medical Signs Three-Year Product Purchase Agreement With Heritage Dialysis Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers…
- benzinga.com Rockwell Medical Raises FY2026 Sales Guidance from $65.000M-$70.000M to $70.000M-$75.000M vs $73.769M Est Rockwell Medical updates its 2026 annual guidance as follows: 2026 Annual GuidanceNet Sales$70.0M to $75.0MGross Margin18% to 22%Adjusted EBITDA$1.0M to $2.0MOperating Cash FlowPositive
benzinga.com Rockwell Medical Q1 Adj. EPS $(0.01) Beats $(0.03) Estimate, Sales $17.336M Miss $17.954M Estimate Rockwell Medical (NASDAQ:RMTI) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.03) by 50 percent. This is unchanged from the same period last year. The…- benzinga.com HC Wainwright & Co. Maintains Buy on Rockwell Medical, Lowers Price Target to $2 HC Wainwright & Co. analyst Raghuram Selvaraju maintains Rockwell Medical (NASDAQ:RMTI) with a Buy and lowers the price target from $2.5 to $2.
benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session 
benzinga.com Earnings Scheduled For March 26, 2026 - benzinga.com Rockwell Medical Sees FY2026 Sales $65.000M-$70.000M vs $75.153M Est GUIDANCEFor the third year in a row, Rockwell Medical's annual performance was directly in line with its annual guidance. In 2025, Rockwell Medical's achieved net sales, gross margin and Adjusted…
- benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session
- benzinga.com HC Wainwright & Co. Reiterates Buy on Rockwell Medical, Maintains $2.5 Price Target HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Rockwell Medical (NASDAQ:RMTI) with a Buy and maintains $2.5 price target.
benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session 
benzinga.com Why Is Rockwell Medical Gaining Tuesday? Rockwell Medical (RMTI) stock rose after announcing preliminary Q4 and full-year 2025 financial results, with sales exceeding estimates.
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session 
benzinga.com Rockwell Medical Delivers Preliminary Full-Year 2025 Results Highlighting Year-Over-Year Revenue Growth To $69.5M, Improved Profitability, And $25M Cash Position Preliminary Unaudited Fourth Quarter and Full-Year 2025 Financial HighlightsThe Company expects net sales for the fourth quarter 2025 to be approximately $18.6 million. The Company expects net sales…
benzinga.com Rockwell Medical Adds 30 New Dialysis Customers in the Western US Amid Supply Disruptions Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers…- benzinga.com HC Wainwright & Co. Maintains Buy on Rockwell Medical, Lowers Price Target to $2.5 HC Wainwright & Co. analyst Raghuram Selvaraju maintains Rockwell Medical (NASDAQ:RMTI) with a Buy and lowers the price target from $3 to $2.5.
- benzinga.com Earnings Scheduled For November 12, 2025
- benzinga.com Rockwell Medical Affirms FY2025 Sales Guidance of $65.000M-$70.000M vs $68.374M Est Rockwell Medical (NASDAQ:RMTI) affirms FY2025 sales outlook from $65.000 million-$70.000 million to $65.000 million-$70.000 million vs $68.374 million estimate.
- benzinga.com Rockwell Medical Q3 Sales $15.927M Miss $16.241M Estimate Rockwell Medical (NASDAQ:RMTI) reported quarterly sales of $15.927 million which missed the analyst consensus estimate of $16.241 million by 1.93 percent. This is a 43.75 percent decrease over sales…
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com Why Carisma Therapeutics Shares Are Trading Higher By 133%; Here Are 20 Stocks Moving Premarket - benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com Why MongoDB Shares Are Trading Higher By 31%; Here Are 20 Stocks Moving Premarket - benzinga.com Rockwell Medical Affirms FY2025 Sales Guidance of $65.000M-$70.000M vs $68.229M Est Rockwell Medical (NASDAQ:RMTI) affirms FY2025 sales outlook from $65.000 million-$70.000 million to $65.000 million-$70.000 million vs $68.229 million estimate.
benzinga.com Rockwell Medical Q2 Adj. EPS $(0.01) Beats $(0.05) Estimate, Sales $16.071M Miss $16.332M Estimate Rockwell Medical (NASDAQ:RMTI) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.05) by 80 percent. This is a 120 percent decrease over earnings of $0.05…- benzinga.com Earnings Scheduled For August 14, 2025
- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
- benzinga.com Rockwell Medical Affirms FY2025 Sales Guidance of $65.00M-$70.00M vs $67.42M Est GUIDANCERockwell confirms its 2025 annual guidance as follows: 2025 Annual GuidanceNet Sales$65.0M to $70.0MGross Margin16% to 18%Adjusted EBITDA($0.5)M to $0.5M
- benzinga.com Earnings Scheduled For May 12, 2025
- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
- benzinga.com HC Wainwright & Co. Maintains Buy on Rockwell Medical, Lowers Price Target to $3 HC Wainwright & Co. analyst Raghuram Selvaraju maintains Rockwell Medical (NASDAQ:RMTI) with a Buy and lowers the price target from $7 to $3.
- benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session
- benzinga.com Rockwell Medical Q4 2024 Adj EPS $0.04 Beats $0.02 Estimate, Sales $24.70M Beat $23.65M Estimate Rockwell Medical (NASDAQ:RMTI) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $0.02 by 100 percent. This is a 100 percent increase over earnings of $0.02…
- benzinga.com Earnings Scheduled For March 20, 2025
- benzinga.com HC Wainwright & Co. Reiterates Buy on Rockwell Medical, Maintains $7 Price Target HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Rockwell Medical (NASDAQ:RMTI) with a Buy and maintains $7 price target.
- benzinga.com Rockwell Medical Scores Multi-Year Dialysis Deal; Stock Jumps Rockwell Medical enters multi-year agreement with leading dialysis provider, expected to generate $10M+ in first year.